Nonrulemaking

Requests that the FDA include additional warnings that should be added to prescribing information on Hormonally-active contraceptives (HCs) and the development of autoimmune diseases

🏛 Food and Drug Administration (FDA)FDA-2026-P-3869

Pharmaceutical Policy

Documents

10

Total comments

0

all analyzed

Comment status

Closed

Last activity

—

In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 10 Supporting & Related Material 9 Other 1

Supporting & Related Material· Apr 15, 2026
Brennan and Klaus 1982→
Supporting & Related Material· Apr 15, 2026
Garcia-Rodriguez 2005→
Supporting & Related Material· Apr 15, 2026
Parello 1997→
Supporting & Related Material· Apr 15, 2026
Aris 2014→
Supporting & Related Material· Apr 15, 2026
Caldwell 2012→
Supporting & Related Material· Apr 15, 2026
Johnson 2004→
Supporting & Related Material· Apr 15, 2026
Murray 2002→
Supporting & Related Material· Apr 15, 2026
Phoenix 2009→
Supporting & Related Material· Apr 15, 2026
Purdom 1994→